Rating History for Conatus Pharmaceuticals (CNAT) by Roth/MKM

More Stocks Rated by Roth/MKM | Latest Ratings for CNAT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/26/2019 Yasmeen Rahimi Downgrade Neutral
(Buy)		 1.70
(N/A)		 1.28
(0.56)		 -56.25% Details